TRPV1 Channels in the Central Nervous System as Drug Targets

Loris A. Chahl

DOI: https://doi.org/10.3390/ph17060756

IF: 4.6

2024-06-08

Pharmaceuticals

Abstract:TRPV1 channels are polymodal cation channels located predominantly on primary afferent neurons that are activated by inflammatory mediators, capsaicin (the active component in chili peppers), and noxious heat. TRPV1 channel antagonists are potential new analgesic agents, but their development has been hindered by the finding that they also produce loss of thermal homeostasis and response to noxious heat. Results from recent studies of the TRPV1 channel indicate that it might be possible to develop TRPV1 channel antagonists that inhibit pain without affecting noxious heat sensation. TRPV1 channels are also present in the central nervous system (CNS) and have been implicated in learning, memory, and behaviour. TRPV1 channel modulators have been proposed to have possible therapeutic potential in the treatment of neurological and psychiatric conditions. However, further understanding of the role of TRPV1 channels in the CNS is required before therapeutic advances in the treatment of neuropsychiatric conditions with TRPV1 channel modulators can be made.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

The paper primarily explores the role of the transient receptor potential vanilloid subtype 1 (TRPV1) channel in the central nervous system (CNS) and its potential as a drug target. Specifically, the paper attempts to address the following key issues:

1. **TRPV1 Channel as a New Target for Pain Treatment**: The TRPV1 channel is a multimodal cation channel primarily located on primary afferent neurons. It can be activated by inflammatory mediators, capsaicin (the active component in chili peppers), and noxious heat. TRPV1 channel antagonists are considered potential new analgesics, but their development has been hindered due to possible side effects such as thermoregulation disorders and loss of sensation to noxious heat.

2. **TRPV1 Channel Antagonists and Thermoregulation**: Although TRPV1 antagonists could theoretically serve as effective analgesics, they cause issues with thermoregulation imbalance and the inability to perceive noxious heat. To develop TRPV1 antagonists that can relieve pain without affecting thermoregulation, a deeper understanding of how the TRPV1 channel regulates body temperature is needed.

3. **Distribution and Function of TRPV1 Channels in the Central Nervous System**: TRPV1 channels are not only present on primary afferent neurons but are also widely distributed in the CNS, including various regions of the brain. These findings have sparked interest in their potential roles in learning, memory, and behavior, as well as their possible use in treating neuropsychiatric disorders.

4. **Association of TRPV1 Channels with Neuropsychiatric Disorders**: The paper also discusses the link between TRPV1 channels and several neuropsychiatric disorders, such as anxiety, depression, addiction, and schizophrenia. Through studies using animal models, the authors explore the potential therapeutic value of TRPV1 channel antagonists or agonists for these diseases.

In summary, this paper aims to delve into the functions of TRPV1 channels in the central nervous system and explore their potential as drug targets for treating pain and neuropsychiatric disorders.